General Inception is pioneering company creation as the first Igniter company. As an Igniter, General Inception brings a new way to partner with inventors to ignite innovation and nurture transformational companies. General Inception becomes a co-founder and brings together domain expertise, seasoned executive talent, infrastructure resources, and capital to nurture and scale growth throughout the entire company journey.
General Inception的外部链接
US，California ，San Francisco
Looking forward to hearing SynthBiome Inc. founder Professor Marvin Whiteley!
LIVE WEBINAR: Join us with Professor Marvin Whiteley for his talk titled "Developing human infection models in a test tube". 21st November at 16.00 CET (10am ET) We'll discuss the perils of using inaccurate biofilm models and how we can bring our lab experiments closer to reality. After registering, you will receive a confirmation email about joining the webinar. https://lnkd.in/gBffx7UX
Looking forward to it! SynthBiome Inc. General Inception
LIVE WEBINAR: Join us with Professor Marvin Whiteley for his talk titled "Developing human infection models in a test tube". 21st November at 16.00 CET (10am ET) We'll discuss the perils of using inaccurate biofilm models and how we can bring our lab experiments closer to reality. After registering, you will receive a confirmation email about joining the webinar. https://lnkd.in/gBffx7UX
”Transforming gene therapy with an advanced AAV delivery platform“ KU Leuven's Trellis Research Group, headed by Prof. Dr. Els Henckaerts, developed an innovative process that equips rAAV vectors with molecules that accurately target them towards their intended locations. This advancement enables more efficient delivery and can help future rAAV gene therapies to have fewer side effects Co-founded with General Inception, KU-LRD and Gemma Frisius Fund in 2023,Tavira Therapeutics is currently in the process of securing additional funding in order to expand the initial proof of principle, grow the team, and ultimately deliver a more efficient and effective therapeutic solution to patients. The appointment of Bob Smith as an independent Chairman further bolsters the already robust team at Tavira. Wishing all the best to Tavira !!! #Tavira Therapeutcs #KU Leuven LRD #Bob Smith
We are thrilled to announce that Tavira Therapeutics has successfully closed our pre-seed funding round! With this funding round we also welcome Bob Smith to the board as our Independent Chairman. A huge thank you to our investors- General Inception and Gemma Frisius Fund and supporters KU Leuven Research & Development (LRD) and the Trellis lab for believing in our vision. Your trust and commitment empower us to innovate and drive meaningful change in the AAV gene therapy field. Stay tuned for more updates as we embark on this exciting journey. Together, we’re building something extraordinary! General Inception KU Leuven Research & Development #FundingAnnouncement #AAV #GeneTherapy #Spinout #Innovation #Capsid #KUL #Leuven https://lnkd.in/eRvrJCRS
It’s common for people to go into the hospital for something innocuous, get an infection, and find that the #bacterium doesn’t respond to #antibiotic. There are strains infecting people outside of clinical settings, as well. As there are millions of deaths caused by this each year, the alarm bells are starting to go off because we are not developing a lot of new antibiotics. ? The premise of Marvin Whiteley's research is that bacterium have begun to behave as a part of sophisticated communication systems whereby they convey information to each other. An example would be “How many bacteria are around me that are like me?” The benefit is being able to coordinate and overcome the immune system toxin production. To see the full show, see link in comments field.
GI launches Igniter Europe !!!! We are delighted to announce that General Inception (GI) is expanding its presence in Europe with the launch of Igniter Europe! This exciting development would not have been possible without the exceptional contributions of our team on both sides of the Atlantic, as well as the support of some of the world's top investors and institutions (#Bpifrance, #KU Leuven, #Paladin Capital Group, in addition to our existing set of investors (Genoa Ventures, OMX Ventures, Northpond Ventures, Paladin Capital Group, Hughes Management Group). We are thrilled to embark on this new venture and are committed to delivering the same level of excellence that our cofounders have come to expect from us to our new cofounders in Europe. Igniter Europe has launched with a portfolio that includes Abbelight, Ennovate Pharma, GauDDi, Nickl Tx, and Tavira Tx. In the future, we plan to support many more scientific founders and deep tech companies in the fields of Therapeutics, Life Science Tools, and Engineered Biology. #GeneralInception #Igniter #deeptech #lifescience #venture Francois Valencony, Venkat Reddy, Paul Conley, Vikram Chaudhery, Pierre GILLET, Océane Fleury, Mourad Yesayan
Illuminate a GI portfolio company with cutting-edge technology: an innovative drug delivery system designed to specifically target tumors, effectively tackling the challenges of safety faced in cancer treatment. Proud to be partnering with Prof. Hayes to bring this technology to patients. #generalinception #illuminate
We are thrilled to have SimBioSys, Inc. as our partner in our pursuit of delivering more effective, personalized cancer therapies! What a great day for patients, physicians and the healthcare system! #illuminate, #Nickl
The Future of Precision Medicine SimBioSys, Inc. meet The Future of Drug Development General Inception. Thrilled to announce this partnership that will enable all drug portfolio companies at General Inception access to our precision cancer care product lines PhenoScope to bring in much needed precision into the drug development process. https://lnkd.in/gPxFbKvw #redefineprecisionmedicine #futureofprecisioncancercare Venkat Reddy Jyoti Palaniappan Patricia C.Joseph Peterson
We are so proud to support Greg Timblin and #InaPill team in their quest to develop therapeutics addressing immunometabolism in multitude of diseases.
What happens when your own immune system attacks you? We'll give you a hint: it's not fun. Inflammation from overactive immune systems causes a wide range of diseases from arthritis to psoriasis. Greg Timblin, CEO of Inapill, has a plan to change that by combining the safety and affordability of over-the-counter NSAIDs with the strength of biologics. Read our latest #TenantSpotlight to learn more about the fascinating science behind Inapill's much-needed technology. https://lnkd.in/gBXiTnUK Also featuring Ingrid Caton, and Venkat Reddy & David Moffat of General Inception
Don't miss General Inception Co-Founder, Vikram Chaudhery, at the Arizona BioPreneur Conference on March 15th! #Startup #Igniter #entrepreneur #growth #venturecaptial
Join me on March 15th at the Arizona BioPreneur Conference to learn from an impressive group of venture capitalists. Vikram Chaudhery, Azin Radsan van Alebeek, Ned Scheetz, and Rik Vandevenne will be discussing how to effectively manage capital to extend runway vs. growth at all costs. Don't miss out on the valuable insights they will share! Register now at: https://lnkd.in/gEZUrYHr
The convergence of biology & technology is transforming the healthcare industry and opening new frontiers. Mark Lehmkuhle, Founder & CEO of Genoa Ventures’ portfolio company Epitel, published an informative overview of how this convergence trend is transforming Neuroscience.
With so many advancements being made every day in healthcare technologies, the remote monitoring market is on a trajectory for rapid growth. In?Labcompare, our CEO/CTO and founder,?Mark Lehmkuhle, Ph.D., delves into the evolution of remote monitoring for brain health and how recent innovations are making a difference for patients and healthcare organizations. Read the full article to understand how the neuroscience monitoring market is evolving and offers insights into the future.? https://lnkd.in/em-kJp39 #Internationalepilepsyawarenessday?#brainhealth?#epilepsyawareness?#seizures?#medtech